Resources
11 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 2/20/2024 (updated 3/28/2024)
Early exposure to Adverse Childhood Experiences (ACEs), (e.g., parental substance use) increases the likelihood of future substance use and drug overdose, resulting in an intergenerational cycle of substance-related ACEs.
Posted 12/12/2023 (updated 3/28/2024)
Given the epidemic of increased maternal mortality and morbidity in the U.S., there is growing sentiment on how to mitigate preventable causes, including that of addressing substance use disorder (SUD). This webinar provided information on the complications of SUD in pregnancy, along with methods for effective intervention and management for clinicians and collaborators.
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 7/26/2023 (updated 3/28/2024)
Sonoran Prevention Works (SPW) shared some of its experiences implementing harm reduction in Cochise County, one of the more rural counties in AZ. SPW provides street-based outreach, testing, and peer support; offers training, education, and technical assistance and TA; and engages in local and state advocacy work.
Posted 7/26/2023 (updated 3/28/2024)
This presentation provided an overview of the (1) current U.S. prevalence of opioid abuse and OUD and their societal consequences, (2) impacts of the opioid epidemic on rural geographic areas and populations, (3) recent emergence of synthetic opioids (e.g., fentanyl) and xylazine in the U.S. drug supply, and (4) most empirically supported treatment for patients with OUD.
Posted 7/26/2023 (updated 3/28/2024)
RSV 2023: 9:00 - 10:45 a.m. Welcome and Keynote Address (Day 1)
Posted 2/11/2022 (updated 4/11/2024)
This packet presents Implementation III grantees with tools and strategies to support implementation activities that expand the options for SUD/OUD services across the care spectrum, thereby helping rural residents in your community to prevent SUD/OUD, access treatment, and move toward recovery.